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To model human neural-cell-fate specification and
to provide cells for regenerative therapies, we
have developed a method to generate human
neural progenitors and neurons from human embry-
onic stem cells, which recapitulates human fetal
brain development. Through the addition of a small
molecule that activates canonical WNT signaling,
we induced rapid and efficient dose-dependent
specification of regionally defined neural progeni-
tors ranging from telencephalic forebrain to poste-
rior hindbrain fates. Ten days after initiation of
differentiation, the progenitors could be trans-
planted to the adult rat striatum, where they formed
neuron-rich and tumor-free grafts with maintained
regional specification. Cells patterned toward
a ventral midbrain (VM) identity generated a high
proportion of authentic dopaminergic neurons after
transplantation. The dopamine neurons showed
morphology, projection pattern, and protein ex-
pression identical to that of human fetal VM cells
grafted in parallel. VM-patterned but not forebrain-
patterned neurons released dopamine and reversed
motor deficits in an animal model of Parkinson’s
disease.INTRODUCTION
The successful derivation of human embryonic stem cells
(hESCs) (Thomson et al., 1998) provided a new model system
for studying human neural development, cell fate commitment,
and neural disease mechanisms (Gaspard and Vanderhaeghen,
2011) and has opened up new strategies for regenerative medi-
cine (Koch et al., 2009a). However, hESC neuralization proto-
cols can be capricious, require extended in vitro culturing,
and often depend on exogenous gene delivery as well as theuse of feeder cells or other undefined components in the
media, which limits their use as model systems and as donor
cells for transplantation. Recent advances in hESC differentia-
tion and lineage commitment have resulted in improved differ-
entiation protocols for more efficient and synchronized neural-
ization of hESCs via dual inhibition of SMAD signaling
(Chambers et al., 2009; Fasano et al., 2010). These protocols
reduce the complexity of neural differentiation as they eliminate
the need for feeder cells. However, they still require the use of
undefined ingredients and animal-derived components (matri-
gel and knockout serum replacement [KSR]), which contain
unknown components that can affect cell phenotype. KSR
and matrigel are also subject to batch-to-batch variations,
further hampering clinical translation (Ahrlund-Richter et al.,
2009; Baker, 2011). In addition, the full range of neural progen-
itors that can be obtained using dual SMAD inhibition has not
been determined and only one study to date shows transplan-
tation data of neural progenitors obtained via dual SMAD inhi-
bition (Kriks et al., 2011).
Here, we report a defined protocol for efficient generation of
subtype-specific and regionalized neurons from hESCs based
on dual SMAD inhibition and embryoid body (EB) formation
(Chambers et al., 2009; Nat et al., 2007). By adding a chemical
inhibitor of glycogen synthase kinase 3 (GSK3), we were able to
induce dose-dependent activation of WNT signaling and
control the positional specification of the cells so that distinct
progenitors, with gene expression profiles matching neural
progenitors from developing human fetal brain, ranging from
telencephalic forebrain to rostral hindbrain fates, could be ob-
tained. The positionally specified progenitors survived trans-
plantation into the adult rat brain and formed neuron-rich grafts
with maintained regional identity after only 10 days of differen-
tiation in vitro. When combined with a high-potency form of
sonic hedgehog (SHH-C24II), we could efficiently pattern the
cultures toward a ventral mesencephalic (VM) fate, yielding
a high number of floor plate progenitors that generated
authentic and functional mesencephalic dopamine (mesDA)
neurons comparable to that obtained from human fetal VM
cells upon transplantation into an animal model of Parkinson’s
disease (PD).Cell Reports 1, 703–714, June 28, 2012 ª2012 The Authors 703
RESULTS
Rapid and Efficient Neural Differentiation of hESCs
Generated Progenitors with Telencephalic Gene
Expression
We developed a neural differentiation protocol for hESCs by
combining dual SMAD inhibition with EB formation (Chambers
et al., 2009; Nat et al., 2007), thereby obtaining a culture setting
of chemically defined reagents free of serum, KSR, and matrigel
and devoid of any manual picking steps (Figure 1A). EBs were
cultured in the presence of SB431542 and noggin for neural
induction and the cell clusters were dissociated to single cells
on day 11 for terminal differentiation (Figures 1A and 1B). The
protocol resulted in rapid and complete downregulation of the
pluripotency-associated genes, OCT4 and NANOG, followed
by induction of the neuronal markers MAP2 and SYP (Synapto-
physin) (Figure 1D). To induce mature neuronal morphologies,
either dibutyryl-cAMP (db-cAMP) or the notch inhibitor N-[N-
(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester
(DAPT) needed to be added to the medium from d14 (Fig-
ure 1C). Quantifications after 21 days of differentiation showed
that over 80% of the cells were MAP2 positive under these
conditions (84.1% ± 4.5% in db-cAMP and 87.2% ± 1.0% in
DAPT, mean ± SEM n = 3). Electrophysiological recordings
demonstrated that the cells exhibited mature functional proper-
ties with trains of tetrodotoxin (TTX)-sensitive action potentials
and whole cell Na+ and K+ currents (Figure 1E; Figures S1A–
S1D available online, n = 9/9). After further maturation, the
neurons received synaptic input and exhibited spontaneous
postsynaptic currents, which were blocked by the glutamate
receptor antagonists NBQX and D-AP5, but not by the
GABAA receptor antagonist picrotoxin (Figure 1F, n = 8/8, day
35). We could not detect any spontaneous inhibitory PSCs in
the neurons (n = 0/12).
To determine the regional identity of the neural progenitors ob-
tained using this protocol, we directly compared gene expres-
sion in different areas of the developing human brain to the
neural progenitors obtained from the hESCs. First, we estab-
lished a quantitative RT-PCR (qRT-PCR) primer panel for more
than 30 genes previously reported to be expressed in distinct
regions of the developing mouse brain using a collection of sub-
dissected human fetal neural tube tissue samples from week
7.5–8 postconception (pc) (Table S1), and confirmed that these
genes showed a similar regionalized expression pattern in the
developing human neural tube (Figures 1G and S1E). Using our
primer panel as a readout for regional identity, we established
that the hESC-derived neural progenitors showed a gene
expression profile consistent with a telencephalic identity, ex-
pressing genes such as OTX2, FOXG1, SIX3, NKX2.1, and
GSX2 in the absence of markers specific for midbrain and hind-
brain (Figure 1G). In accordance with the anterior neuroectoder-
mal gene expression profile of our cultures and the fact that the
rostral part of the neural tube is void of a floor plate structure
(Placzek and Briscoe, 2005), we did not observe induction of
floor plate markers when ventralizing our cultures with a high
potency form of SHH (Figure 1G). We hypothesized that caudal-
izing agents were necessary to generate floor plate cells from
more posterior brain regions.704 Cell Reports 1, 703–714, June 28, 2012 ª2012 The AuthorsDose-Dependent Activation of Canonical WNT Signaling
Is Sufficient toMimic Positional Patterning of the Neural
Tube in Differentiating hESCs
Members of the WNT family are involved in early caudalization of
the cells in the neural plate (Nordstro¨m et al., 2002). The canon-
ical WNT signaling pathway depends on inhibition of GSK3 for
stabilization and activation of b-catenin. Accordingly, chemical
inhibition of GSK3 can activate canonical WNT signaling and
induce expression of downstream WNT targets (Frame and Co-
hen, 2001). We tested the GSK3 inhibitor CT99021 (CT), and
confirmed that it activated canonical WNT signaling in differenti-
ating hESC in a dose-dependent manner, as shown by increased
nuclear accumulation of b-catenin and activation of the WNT
target gene LEF1 (Figures 2A and 2B). We also ensured that
neural induction and maturation was unaffected by the
compound by monitoring expression of the neuronal markers
MAP2 and SYP throughout the dose-response curve (Figures
S2B and S2C).
We next examined the gene expression profile of neural
progenitors formed at different concentrations of the GSK3
inhibitor. When compared to expression profiles of the sub-
dissected human neural tube, we found that we could obtain
neural progenitors from all regions of the rostrocaudal axis
ranging from telencephalon (CT = 0 mM) to posterior hindbrain
(CT = 4 mM, Figures 2C and S2A). At CT concentrations
below 0.4 mM, the cultures expressed high levels of telence-
pahlic markers FOXG1, LHX2, DLX2, NKX2.1, GSX2, and
SIX3 in the absence of any markers specific for midbrain
and hindbrain. The gene IRX3, which is expressed caudal
to the zona limitans interthalamica, only appeared at concen-
trations above 0.4 mM. OTX2, which is expressed rostral to
the midbrain-hindbrain boundary, was highly expressed at
CT concentrations below 1 mM and decreased to undetect-
able levels above this concentration. The dramatic drop in
OTX2 expression coincided with a peak in WNT1 expression,
which is expressed at the midbrain-hindbrain boundary.
These markers indicated that CT concentrations below
1 mM led to rostral identities, whereas CT concentrations
above 1 mM led to the production of cell fates caudal to
the midbrain-hindbrain boundary. Indeed, hindbrain markers
GBX2, HOXA2, and HOXA4 were only expressed at CT
concentrations of 1–4 mM. In line with the expression pattern
of rostral and caudal markers, we observed induction of
midbrain fates at a very narrow concentration range of 0.7–
0.8 mM. This was evident as peaks of expression of PAX5,
LHX1, LMX1A, LMX1B, SIM1, EN1, and EN2 (Figures 2C
and S2A). We established that most genes were expressed
at similar levels in our regionalized cultures as in equivalent
regions of the human fetal brain (PC week 7.5–8) (Figure S1).
When the cells were differentiated toward diencephalic,
midbrain, and hindbrain fates (CT 0.4–2 mM), we observed a
significant induction of floor plate markers FOXA2, FOXA1,
SHH, and CORIN, congruent with an existing floor plate
structure in these regions (Figures 2C and S2A). To confirm
the robustness of our protocol, we repeated the differentia-
tions in another hESC line, SA121 (Heins et al., 2006), and
obtained an identical rostrocaudal differentiation pattern
(Figure S2D).
Figure 1. Protocol for Neural Differentiation of hESCs
(A) Overview of differentiation protocol for hESCs. NB, neurobasal; AA, ascorbic acid.
(B) Bright-field images of differentiated cells at different days of differentiation.
(C) Only differentiation in the presence of db-cAMP or DAPT from day 14–30 yielded cultures rich in MAP2 (green). BGA = BDNF+GDNF+AA.
(D) Graphs showmRNA levels of pluripotency markersOCT4 andNANOG and neuronal markersMAP2 and SYP during differentiation, relative to undifferentiated
H9 hESCs (= d0).
(E) Representative traces of membrane potential changes recorded in current-clamp mode showing trains of action potentials (upper panel), and TTX-inhibited
trains of action potentials generated in response to a depolarizing current-ramp (lower panel). Action potentialswere detected in 9 out of 9 recorded neurons (d25).
(F) Representative traces of spontaneous postsynaptic currents (PSCs) recorded at a holding potential of 70 mV in the presence or absence of the GABAA
receptor antagonist picrotoxin or the glutamate receptor antagonists, NBQX and D-AP5 (n = 8, d35).
(G) Gene expression in human fetal brain and H9 cultures differentiated in the absence or presence of 200 ng/ml SHH. All expression levels are normalized to levels
detected in human tissue (= 100%). Red: Rostral markers (normalized to forebrain), blue and green: midbrain markers and floor plate markers, respectively
(normalized tomidbrain), andpurple: caudalmarkers (normalized tohindbrain).Dataare representedasmean±SEM,n=3 fordifferentiatedhESCs.For tissue, n=1.
See also Figure S1 and Table S1.Control of Rostrocaudal Fates Can Be Combined with
Control of Dorsoventral Fates
To explore if it was possible to also control the dorsoventral range
of cell fates at any given rostrocaudal position, we administered
varying concentrations of SHH (0, 200, or 500 ng/ml) combinedwith a fixed concentration of CT (0.7 mM = midbrain fate). Since
noggin and SB431542 are potent inhibitors of bone morphoge-
netic protein (BMP) signaling, we included a SHH-free condition
in which noggin and SB431542 (NSB) were withdrawn from the
cells after 4 days of differentiation to allow for activation ofCell Reports 1, 703–714, June 28, 2012 ª2012 The Authors 705
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markers FOXA1, NTN1, CORIN, and SHH as well as basal plate
markers SIM1, NKX6.1, and LHX1 were only expressed in the
presence of SHH (Figures 2D and 2E). While there was a trend
for expression of floor plate markers to increase with increasing
concentrations of SHH (Figure 2D), the basal plate markers
showed a tendency to decrease (Figure 2E). In the absence of
SHH, PAX6 as well as roof plate markers GDF7, PAX7, and
WNT1 were expressed (Figure 2F). Induction of roof plate
markers was particularly pronounced when NSB was withdrawn
from themedium on day 4 of differentiation (NSB d0–4). The tran-
scription factor LMX1A was induced by SHH and also by NSB
withdrawal, reflecting the endogenous expression of LMX1A,
which is present in both the roof plate and floor plate of the devel-
oping human midbrain (Figure 2G). Pan-midbrain markers and
hindbrain markers OTX2 and GBX2 were not significantly
affected by patterning across the dorsoventral axis (Figure S2E).Transplanted Neural Progenitors of Rostral, Midbrain,
and Caudal Fates Survive and Form Neuron-Rich,
Tumor-free Grafts in the Adult Rat Brain
We next transplanted neural progenitors of distinct positional
identity after 10 or 16 days of differentiation into the striatum of
adult rats. Groups of rats were transplanted with differentiated
hESCs corresponding to three different ventralized regional
fates: rostral d10 (SHH, n = 4), midbrain = VM d10 and d16
(SHH + 0.7 mM CT, n = 16 and n = 16, respectively), and caudal
d10 (SHH + 2 mM CT, n = 7). Six weeks posttransplantation, we
observed that all of the grafted animals (total of 43) had surviving
transplants and none of the grafts showed signs of aberrant
features such as tumor formation or necrosis, indicating that
the transplanted cells were well tolerated and contained no
obvious contamination of undifferentiated hESCs. The VM-spec-
ified cells tended to form the largest transplants and grafting of
VM-specified cells on day 16 of differentiation did not affect
the graft size or survival compared to day 10 (Figures 3A–3C,
3G, and 3H). After 6 weeks, the grafts from all fates were rich
in NESTIN expression, indicating the presence of neural progen-
itors (Figure 3I), which was also supported by the presence of
some proliferating cells at this time point. The forebrain groupFigure 2. Regionalization of H9 Cultures with CT99021
(A and B) H9 cells differentiated for 24 hr in the presence of CT showed (A)
increased nuclear intensity of b-catenin immunoreactivity (n = 4), see also
Figure S5, and (B) upregulated mRNA levels of the WNT signaling target LEF1
(n = 4). *p < 0.05, **p < 0.01, Student’s t test.
(C) Gene expression of H9 cells differentiated in the absence of factors, or in
the presence of SHH combined with CT (from 0 to 4 mM). For each gene, the
expression levels were normalized to the cell sample with the highest level
observed (= 100), and the values have been color-coded as shown.
Comparative expression in human fetal brain samples and in undifferentiated
hESCs is shown on the left side of the heatmap (v = ventral). n = 4–5.
(D–G) Dorsoventral gene expression with varying SHH and BMP levels for (D)
floor plate markers, (E) basal plate markers, (F) dorsal markers, and (G) the
transcription factor LMX1A, which is expressed in both the roof plate and
floor plate region. All expression values are represented as mean fold
change ± SEM relative to the differentiated sample with the highest expression
level (= 100), n = 3–4. See also Figure S2 for full graphs of rostrocaudal
patterning and Table S1 for primer sequences.
Figure 3. Overview of Survival and Prolifer-
ation in Grafts from Regionally Specified
hESCs at 6 and 18 Weeks Posttransplanta-
tion
(A–C) Grafts resulting from hESCs differentiated
for 10 days in vitro patterned toward rostral (SHH),
VM (SHH + 0.7 mM CT), or caudal fates (SHH +
2 mM CT).
(D–F) All regions generated neuron-rich grafts as
visualized with human-specific NCAM.
(G) hESCs differentiated for 16 days in vitro
generated similar grafts.
(H) Assessment of graft volume showed slightly
larger grafts in the VM-patterned groups.
(I andJ)Neuralmaturationwasassessedat 6 (I) and
18 (J) weeks in theVMcondition,with a decrease in
expression of NESTIN+ cells at the later time point.
Data are presented as mean ± SEM.
(K) In the rostral fate, immature neural progenitors
were present also 18 weeks posttransplantation.
(L–O) Ongoing proliferation was assessed using
PCNA, with the host subventricular zone (SVZ)
used as an internal control (graft-host border
delineatedwith a dashed line). At 6weeks, both VM
and rostral conditions showed ongoing prolifera-
tion, but after 18 weeks only rare proliferating cells
could be detected in VM group.
Scale: Coronal overlays in (A)–(C) = 4mm; (D)–(G) =
250 mm; (I)–(K) = 75 mm; (L)–(O) = 150 mm. See also
Figure S3 for subtype analyses and graft densities.contained proliferating PCNA+ cells in characteristic rosette-like
structures, whereas PCNA+ cells in the midbrain and caudal
grafts were dispersed throughout the graft (Figures 3L, 3N, and
S3). All grafts contained a high proportion of neurons as deter-
mined by staining for human-specific neural cell adhesion mole-
cule (hNCAM) (Figures 3D–3F). The majority of the neuronal
innervation was restricted to the graft core in all three groups
although we also observed an affinity for axonal outgrowth in
white matter tracts, such as the corpus callosum. At 6 weeks,
hNCAM+ fibers could be detected in the internal capsule. Addi-
tionally, the forebrain transplants showed some fibers entering
the thalamus, whereas the midbrain group more extensively
innervated the striatum and some projections were detected in
the amygdala and SNr (Figure S4), similar to what has been
observed in xenografts of forebrain and midbrain tissue, respec-
tively (Isacson et al., 1995; Wictorin et al., 1990, 1992).
A High Purity of Transplantable mesDA Progenitors Are
Formed at a Narrow Concentration Range of GSK3
Inhibitor
To investigate if the regionalizing progenitors could give rise to
authentic and functional neurons, we focused the study on the
production of mesencephalic DA (mesDA) neurons. In the devel-
oping embryo, the mesDA progenitors arise from the floor plateCell Reports 1, 703–7and coexpress FOXA2 and LMX1A (An-
dersson et al., 2006; Ferri et al., 2007;
Hebsgaard et al., 2009; Nelander et al.,
2009; Bonilla et al., 2008; Ono et al.,2007). As determined from our gene expression analysis,
midbrain floor plate markers were efficiently induced at a narrow
concentration range of 0.7–0.8 mM CT in combination with SHH
(Figures 2C and S2A). Immunocytochemical analysis confirmed
that FOXA2 and LMX1A protein were abundantly coexpressed in
the VM condition, but not in the more rostral or caudal hESC-
derived progenitors in vitro (Figure 4A). The FOXA2+/LMX1A+
cells in our cultures also expressed the midbrain marker EN1
(Figure 4B) and, like their in vivo counterparts, coexpressed
CORIN, thus confirming their floor plate identity (Figures 4E
and 4F). The regionalized phenotype of the progenitors was
maintained after grafting as the majority of cells in the midbrain
group coexpressed LMX1A and FOXA2 at 6 weeks after graft-
ing, whereas none could be detected in the forebrain or hind-
brain groups (Figure 4C). In line with this, VM-specified progen-
itors generated high numbers of DA neurons both in vitro and
in vivo, whereas TH+ neurons were absent in equivalent grafts
from forebrain- and hindbrain-specified progenitors (Figures
4G and S3).
To confirm the authenticity of our stem cell-derived VM
progenitors, we performed a direct histological comparison of
hESC-derived VM and human fetal VM at 6 weeks after grafting
into the 6-hydroxydopamine (6-OHDA)-lesioned rat striatum.
The fetal VM was subdissected from human embryos age14, June 28, 2012 ª2012 The Authors 707
Figure 4. Specification of VMCells in Differ-
entiated hESCs
(A) Cells expressing FOXA2 and LMX1A were
abundant only when hESCs were differentiated in
the presence of SHH and 0.7–0.8 mM CT (d11 of
differentiation).
(B) These cells also expressed the midbrain
marker EN1.
(C) VM-patterned cells maintained expression of
FOXA2 and LMX1A 6 weeks after grafting into rat
brain.
(D) The number of FOXA2/LMX1A double-positive
cells was significantly higher in hESC-derived VM
cultures compared to dissociated subdissected
fetal VM. Data are presented as mean ± SEM.
***p < 0.001, Student’s t test.
(E) Expression of FOXA2, LMX1A, and CORIN at
day 14 in H9 cultures differentiated toward VM
fates. The vast majority of cells coexpressed all
three markers.
(F) Immunohistochemical analysis of FOXA2,
CORIN, and LMX1A in human fetal VM tissue (pc
week 7.5). CORIN is localized to mesDA progeni-
tors in the medial region of the FOXA2/LMX1A
domain.
(G) Long-term differentiation of VM-specified cells
generated large numbers of FOXA2+/TH+ neurons
(day 42). Scale bar = 200 mm in (A) and (C) and
100 mm in (B) and (E)–(G).
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6.5–7 weeks pc, and the transplanted tissue preparation con-
tained an average of 21% of the cells coexpressing LMX1A
and FOXA2, compared to 81% for the hESC-derived VMcultures
(Figure 4D). Accordingly, the hESCs gave rise to 15-fold more
TH+ neurons in the grafts as compared to fetal VM tissue;
8,338 ± 1,920 (n = 8) versus 558 ± 119 (n = 5) per 100,000 grafted
cells (p < 0.001) (Figure 6G). A side-by-side comparison of hESC-
derived and fetal-derived DA neurons showed virtually indistin-
guishable phenotypes. EN1 and NURR1 colocalized with
LMX1A/FOXA2 and TH/FOXA2 in both the human fetal VM and
hESC-derived VM grafts, and many of the neurons from both
sources coexpressed TH and aromatic L-amino acid decarbox-
ylase (AADC) (Figures 5A–5F). Close inspection of the
morphology of the TH+ neurons from both cell sources (Figures
5G and 5H) revealed bipolar, angular cell bodies with elongated
primary axons located at the periphery of the transplants, which
is typical of grafts of fetal VM (Mendez et al., 2005; Thompson
et al., 2005). When assessing fiber outgrowth at 6 weeks post-
transplantation, we observed similar regional innervation
patterns from fetal VM grafts and hESC VM grafts including
innervation to the dorsolateral striatum (Figures 5I, 5J, and S4).
Grafts from hESC-Derived VM Progenitors Release DA
In Vivo and Reverse Motor Impairments in 6-OHDA-
Lesioned Rats
To assess long-term survival and function of the positionally
specified hESC-derived progenitors, VM and forebrain
patterned cells were grafted in parallel into 6-OHDA-lesioned
adult rats and kept under ciclosporin-mediated immunosup-
pression for the duration of the experiment. After 18 weeks,
the forebrain cells remained tightly clustered in the graft,
whereas the VM-patterned cells had dispersed into the host
striatum; the density of VM-patterned grafts were 1165 HuNu+-
nuclei/mm2 at 6 weeks compared to 634 HuNu+ nuclei/mm2 at
18 weeks (n = 4 per group, see also Figure S3). At this point,
the midbrain group contained only a few NESTIN-expressing
cells and cell proliferation was minimal (Figures 3J and 3M).
Pockets of proliferating cells were still present in the forebrain
group, which also contained some NESTIN-expressing progen-
itors, indicating a prolonged proliferation and slower maturation
of the forebrain-specified grafts (Figures 3K and 3O). The rostral
grafts remained devoid of DA neurons after 18 weeks, whereas
54.2% ± 2.5% of cells in the hESC VM grafts were TH positive
(% TH+/HuNu+, mean ± SEM, n = 3, see also Figures 6A and
6B). Both the total number of DA neurons (Figure 6G) and the
graft-derived innervation of the host striatum increasedmarkedly
between 6 and 18 weeks posttransplantation in grafts of VM-
patterned hESCs (Figures 6D and 6D0 compared to Figure 5J).
The neurons displayed a morphology characteristic of mesDA
neurons and a large proportion also expressed GIRK2, typical
of nigral A9 DA neurons (Thompson et al., 2005) (Figure 6F).
In vivo amperometric measurements showed that the grafts
derived from the VM group, but not the forebrain group, released
dopamine 18 weeks after transplantation (Figure 6C) at levels
comparable to previous reports of grafts of human fetal
VM and mouse ES cells (Rodrı´guez-Go´mez et al., 2007; Stro¨m-
berg et al., 1989). Accordingly, hESC-derived VM patterned
cells reversed amphetamine-induced rotational asymmetry in6-OHDA-lesioned rats, while the rats grafted with forebrain
patterned cells showed no change in rotational response after
12 or 16 weeks (Group 3 Time, c2(10,96) = 75.09, p < 0.0001;
posttransplantation difference confirmed using a Bonferroni-
adjusted one-way ANOVA with a Tukey post hoc test, p <
0.01) (Figure 6H). In the cylinder test, a measure of forelimb aki-
nesia, the rats grafted with VM-patterned cells showed a signifi-
cant increase in touches using the affected pawwhen compared
to the lesion control group, while the forebrain patterned cells did
not (Group, F(2,14) = 5.00, p < 0.05; confirmed using a Tukey post
hoc test) (Figure 6I).
DISCUSSION
In this study, we combined dual SMAD inhibition with EB
formation (Chambers et al., 2009; Nat et al., 2007) to achieve
a rapid and efficient neural differentiation protocol devoid of
any manual picking steps and undefined biological compo-
nents. In the absence of positional cues, the progenitors de-
faulted into an anterior neural identity similar to what has
been reported for other ES differentiation paradigms (Gaspard
et al., 2008; Li et al., 2009; Pankratz et al., 2007). Concurrent
chemical activation of the canonical WNT pathway caused
a progressive dose-dependent induction of caudal cell fates
analogous to the caudalizing effect of WNTs in the early devel-
oping neural tube (Nordstro¨m et al., 2002). Although WNT
signaling is also known to be involved in dorsoventral
patterning (Ulloa and Martı´, 2010), we could nonetheless accu-
rately control the full range of fates from floor plate to roof plate
when combining WNT activation with modulation of SHH and
BMP signaling. Therefore, our system can be used to rapidly
generate region-specific neural progenitors with a high simi-
larity to neural progenitors from different levels of the devel-
oping human neural tube, and with the capacity to mature
into subtype-specific neurons.
A particularly striking observation was that our neural progen-
itors could be grafted into the rodent brain as early as 10 days
after neural induction with good survival, high neuronal differen-
tiation, and maintained regional specification. Despite the short
culture time prior to transplantation, the grafts showed no signs
of tumor formation or necrosis, which are features otherwise
commonly associated with transplantation of progenitors
derived from pluripotent stem cells (Miura et al., 2009; Roy
et al., 2006). This is a significant advancement over existing
protocols (Aubry et al., 2008; Brederlau et al., 2006; Chiba
et al., 2008; Kriks et al., 2011; Seminatore et al., 2010) since it
eliminates the need for prolonged culturing prior to transplanta-
tion, making it cost effective, and reducing the variation and
asynchrony associated with extended in vitro differentiation prior
to transplantation.
By selecting the appropriate combination of developmentally
relevant extrinsic patterning agents, we could generate hESC-
derived neural progenitors with the same gene and protein
expression profile as DA progenitors in the developing human
VM. In our protocol, 0.7–0.8 mM CT represented the optimal
concentration for inducing midbrain fates and higher concentra-
tions yielded progenitors of a more caudal identity, as deter-
mined by onset of expression of GBX2 and other caudalCell Reports 1, 703–714, June 28, 2012 ª2012 The Authors 709
Figure 5. Phenotypic Comparison of Human Fetal VM Grafts and Their hESC-Derived Counterparts
(A–D) The phenotypic profile of transplants from (A) fetal VM and (B) hESC-derived VM cells were compared using a selection of regional markers identifying
mesDA neurons: EN1, LMX1A and FOXA2. Mature markers TH, NURR1 and FOXA2 were also compared between (C) the fetal VM and (D) their hESC-derived
counterparts.
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markers. This finding differs from a recent study in which mesDA
neurons were obtained via dual SMAD inhibition using 3 mM of
the same CT compound (Kriks et al., 2011). We speculate that
this discrepancy may be due to the fact that CT was present
from day 0 of differentiation in our protocol, whereas treatment
was initiated 2 days later in the study of Kriks et al. The presence
of undefined components in the KSR and matrigel used in the
latter study might also contribute to differential modulation of
external patterning effects.
From the side-by-side comparisons of hESCs and fetal VM
cells, we found that our hESC-derived progenitors had virtually
indistinguishable gene and protein expression. Likewise,
6 weeks after transplantation, the neurons obtained from the
two cell sources had a similar morphology, expressed the
same mature DA markers and mesDA-specific proteins, and
projected to the same target structures. After 18 weeks of matu-
ration of the midbrain-patterned hESC-derived grafts, the cells
had dispersed into the host parenchyma, where they extensively
innervated the striatum and released DA. Their functional effi-
cacy was confirmed through complete reversal of amphet-
amine-induced rotational asymmetry, as well as increased use
of the affected forelimb in a unilateral animal model of PD,
matching what has previously been established using human
fetal VM (Brundin et al., 1988).
With few exceptions (Cooper et al., 2010; Kriks et al., 2011),
most previously published protocols derive DA neurons from
cultures mainly comprised of PAX6 expressing neural progeni-
tors (Koch et al., 2009b; Perrier et al., 2004; Roy et al., 2006;
Sonntag et al., 2007; Swistowski et al., 2009). PAX6-derived
DA neurons have since been shown to be mainly of a dience-
phalic DA subtype (Cooper et al., 2010), but for cell therapy in
PD the A9 mesDA phenotype is essential (Grealish et al.,
2010; Zuddas et al., 1991). The improvement in motor function
of the mesDA neurons generated using our protocol is compa-
rable to what was reported by Kriks et al. (2011) when assayed
in a rat model of PD. These studies suggest that protocols,
which recapitulate developmental pathways, are necessary to
generate authentic and functional DA neurons. From a clinical
perspective, advantages with our protocol are that we have
extensively established the authenticity of progenitors and
neurons using fetal VM as comparison, confirmed DA release,
avoided the use of undefined components in the media, and
that the cells required a much shorter culturing time in vitro prior
to grafting.
In summary, we show that dose-dependent activation of WNT
signaling in hESCs is a simple and efficient method for gener-
ating transplantable and authentic progenitors from the entire
rostrocaudal neural axis. The hESC-derived progenitors and re-
sulting neurons obtained via our protocol closely resembled their
fetal counterparts, making them useful as a model system for
studies of human fetal brain development and also for devel-
oping successful stem cell-based therapies for neurodegenera-
tive diseases.(E and F) Markers of dopamine metabolism were assessed by expression of TH
(G and H) Typical mesDA morphology was distinguished using TH immunohistoc
(I and J) Dark-field images show innervation of the host striatum.
Scale bar = 200 mm. See also Figure S4 for innervation patterns.EXPERIMENTAL PROCEDURES
Human Fetal Tissue
Human fetal tissue was obtained from subdissections of aborted fetuses (pc
week 6–8, determined by crown-rump length) donated under informed consent
with approval of Lund Regional Ethical Committee and the Swedish national
boardofhealthandwelfare. Immunohistochemistrywasperformedaspreviously
described (Nelander et al., 2009). For quantification of LMX1A and FOXA2,
human fetal VMwas subdissectedand triturated toyield single-cell suspensions.
The cells were immobilized onglass slides by cytospin followedby fixation in 4%
paraformaldehyde (PFA) for immunocytochemistry. Before transplantation, the
human fetal VM was stored in hibernation medium at 4C overnight followed
by dissociation at 37C for 10–15 min in 0.1% trypsin/0.05% DNase diluted in
HBSS (Invitrogen). The cells were washed three times before transplantation.
Cell Culture and Differentiation Procedure
All cell culture reagents were from Invitrogen unless stated otherwise. Human
ESCs H9 (WA09, passage 31–45 (Thomson et al., 1998) and SA121, passage
25–35 (Heins et al., 2006) were maintained on g-irradiated mouse embryonic
fibroblasts in DMEM/F12, 20% KSR, 0.05 mM 2-mercaptoethanol, 0.5% Pen/
Strepand10ng/mlFGF-2 (R&DSystems).Thecellswerepassagedonceweekly
with dispase (5 mg/ml, Stemcell Tech.). For differentiation, the colonies were
detached with dispase and EBs were formed in DMEM/F12:Neurobasal (1:1),
N2 supplement (1:100), and B27 supplement without vitamin A (1:50). Rock
inhibitor (Y-27632, 10 mM, Tocris Biochem.) was present from d0 to d2. On d4
of differentiation, the EBs were plated in DMEM/F12:Neurobasal (1:1), N2
supplement (1:200), andB27 supplementwithout vitamin A (1:100) onto plastic-
ware coatedwith polyornithine (PO), fibronectin (FN), and laminin (lam). Fromd0
to d9, SB431542 (10 mM, Tocris Biochem.) and Noggin (200 ng/ml, R&D) was
present in the medium for neuralization (unless stated otherwise in the text).
Patterning factors SHH-C24II (R&D, 200 ng/ml unless stated otherwise), and
CT99021 (Axon Medchem) were also present in the medium from d0 to d9. On
d11of differentiation, the cell clusterswere dissociated to single cellswith accu-
tase and replated onto dry PO/FN/lam-coated plates in droplets of 5–15,000
cells/ml in Neurobasal, B27 supplement without vitamin A (1:50), brain-derived
neurotrophic factor (BDNF) (20 ng/ml), glial cell line-derived neurotrophic factor
(GDNF) (10ng/ml), andascorbicacid (200mM). Fromd14andonward, db-cAMP
(0.5mM) or DAPT (2.5 mM)was added to themedium for terminal differentiation.
Quantitative RT-PCR
Quantitative RT-PCR was performed using Sybr Green detection with the
LightCycler 480 instrument (Roche). See Extended Experimental Procedures
for primer sequences and details.
Electrophysiology
Plated cells were constantly perfused with heated (32C–34C), gassed (95%
O2, 5% CO2) solution (pH 7.2–7.4, 295–300 mOsm) containing (in mM): 119
NaCl, 2.5 KCl, 1.3 MgSO4, 2.5 CaCl2, 26 NaHCO3, 1.25 NaH2PO4, and 25
glucose. Cells for recording were visualized under infrared light with differential
interference contrast using an Olympus upright microscope equipped with
a digital camera and a 403 water-immersion lens. Recording pipettes were
filled with solution (pH 7.2–7.4, 295–300 mOsm) containing (in mM): 122.5
potassium gluconate, 12.5 KCl, 10.0 KOH-HEPES, 0.2 KOH-EGTA, 2 MgATP,
0.3 Na3-GTP, and 8 NaCl, resulting in pipette resistances of 3–5 MU. For
measurements of spontaneous inhibitory postsynaptic currents recording
pipettes contained (in mM): 135.0 CsCl, 10.0 CsOH, 0.2 CsOH-EGTA, 2 Mg-
ATP, 0.3 Na3-GTP, 8 NaCl, and 5 lidocaine Nethyl bromide (QX-314, Tocris),
resulting in pipette resistances of 3–4 MU. Postsynaptic currents were
measured in voltage clamp at 70 mV. GABAA receptors were blocked using
100 mMpicrotoxin (PTX, Tocris). N-Methyl-D-aspartate and a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptorswereblockedusing50mMand AADC.
hemistry.
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Figure 6. hESC-Derived VM Grafts Release Dopamine and Reverse Motor Deficits at 18 Weeks Posttransplantation in a Rat Model of Par-
kinson’s Disease
(A and B) Adult rats were subjected to 6-OHDA lesions for unilateral depletion of TH+ neurons, and subsequently received transplants of hESC-derived cells
patterned toward (A) VM or (B) rostral fates. Coronal sections from 18 weeks posttransplantation show that VM cells efficiently differentiated into DAergic
neurons, whereas the rostral cells did not.
(C) Dopamine release was measured using in vivo amperometry at a series of dorsoventral depths within the grafted striatum (as depicted). Potassium-evoked
release events were only observed in the hESCVMgroup. Recordings from individual animals that exemplify each group are shown to the left and DA release from
all recorded animals (n = 3 from each group) to the right.
(D) Dark-field overview of TH+ graft-derived innervation from an animal transplanted with hESC VM cells showed extensive innervation of the host striatum after
18 weeks survival, in particular, the dorsolateral striatum (D0 ).
(E) TH immunohistochemistry revealed angular neurons at the graft edge, extending processes into the host striatum.
(F) GIRK2+/TH+ neurons were frequently observed in grafts of hESC VM cells.
(G) Estimation of surviving TH+ neurons normalized to number of cells grafted, n = 4 for all groups.
(H) Animals transplanted with hESC VM cells (n = 6) normalized amphetamine-induced rotation after 12 weeks posttransplantation while rats with grafts of rostral
cells (n = 7) showed no reduction in drug-induced rotations at any time point analyzed (n = 6 for lesion control).
(I) hESC VM grafted animals (n = 6) displayed significantly more paw touches than lesion control rats (n = 6) when tested in the cylinder at 14 weeks post-
transplantation, while the animals receiving hESC rostral grafts (n = 7) showed no significant difference from controls.
All data in graphs are presented as mean ± SEM. *p < 0.001 (hESC VM versus hESC rostral and lesion control), **p< 0.0001 (hESC VM versus hESC rostral and
lesion control), yp < 0.05 (hESC VMversus lesion control), xp < 0.0001 (hESC VM versus hESC rostral), #p < 0.0001 (Fetal VM versus hESCVM6 and 18weeks), !p
< 0.0001 (hESC VM 6 versus hESC VM 18 weeks).(2R)-amino-5-phosphonovaleric acid (D-AP5, Tocris) and 5 mM2,3-dihydroxy-6-
nitro-7-sulfamoylbenzo[f]quinoxaline-2,3-dione (NBQX, Tocris), respectively.
Voltage-gated sodiumand potassiumchannelswere blockedwith 1 mMtetrodo-
toxin (TTX, Tocris) and 2 mM tetraethylammonium (TEA, Sigma), respectively.712 Cell Reports 1, 703–714, June 28, 2012 ª2012 The AuthorsLesions and Transplantation Surgery
Adult female Sprague-Dawley rats (225–250 g, Charles River) were housed in
a 12-hr-light/dark cycle with ad libitum access to food and water. All experi-
mental procedures were conducted following the guidelines put in place by
the Ethical Committee for the use of Laboratory Animals in Lund University.
Surgical procedures were conducted under general anesthesia using a 20:1
fentanyl and medetomidine solution injected intraperitoneally (Apoteksbola-
get, Sweden). The rats were made parkinsonian by injecting 6-OHDA into
the medial forebrain bundle for complete lesion of the nigrostriatal dopami-
nergic pathway in the right hemisphere (see Extended Experimental Proce-
dures). At least 4 weeks postlesion, cells were transplanted into the striatum
using a microtransplantation approach as previously described (Nikkhah
et al., 2000). For differentiated hESCs, 23 1 ml deposits of 75,000 cells/ml (total
of 150,000 cells) were transplanted for d10, or for d16: 2 3 2 ml deposits of
75,000 cells/ml (total of 300,000 cells). Immunosuppressive treatment was
given for the duration of the experiment, in the form of daily intraperitoneal
injections of ciclosporin (10 mg/kg), beginning 1 day prior to transplantation.
Immunostaining, Imaging, and Quantifications
For a complete list of antibodies and dilutions used in this study, see Table S2.
Nuclear b-catenin intensity in hESCs was quantified through automated image
acquisition and analysis using the Cellomics instrument and software from
Thermo Scientific (see Figure S5). Each experiment was averaged from two
wells with 1,500 analyzed cells in each well. See Extended Experimental
Procedures for procedures on quantification of graft volume and number of
TH+ cells in the grafts.
Behavioral Analyses
Amphetamine-induced rotation was performed using automated rotational
bowls (AccuScan Instruments). D-Amphetamine sulfate at a dose of 2.5 mg/
kg was delivered intraperitoneally and full-body rotations were recorded
over a period of 90 min. The data are expressed as net full body turns per
minute, where rotation toward the side of the lesion was given a positive value.
A two-way ANOVA was performed on amphetamine-induced rotation data
using the generalized linear model and the Wald c2 test. The cylinder test
was performed as a measure of forelimb use, where animals were placed indi-
vidually in a glass cylinder and spontaneous weight-bearing forepaw contacts
with the glass were counted. For in-depth details please refer to Grealish et al.
(2010).
Amperometry
Chronoamperometric measurements of evoked dopamine release were per-
formed using Fast Analytical Sensing Technology apparatus (FAST-16, Quan-
teon LLC, Lexington, KY) coupled to carbon fiber electrodes (SPF1, Quanteon
LLC) coated with Nafion (Sigma Aldrich, Sweden) as previously described
(Hoffman et al., 1998). Dopamine release was evoked by application of fixed
amount (200 nl) 120 mM KCl adjacent to the recording electrode. Dopamine
concentration was continuously monitored at 1 Hz. The peak amplitude
concentration was calculated using FAST analysis software (Quanteon,
LLC). The recording electrode was stereotactically placed at the same ante-
rior-posterior and lateral coordinates as the previous graft implantation
surgery. Three KCl ejections (5 min intervals) were made every 250 mm
between 3.0 and 5.5 mm from dural surface. The average peak amplitude
was calculated from each recording site.
Statistical Analysis
All pooled data are presented as mean ± SEM. Statistical tests and number of
biological replicates relevant for individual experiments are stated in Results or
in the figures legends.
SUPPLEMENTAL INFORMATION
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